Media stories about GNC (NYSE:GNC) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. GNC earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the specialty retailer an impact score of 46.7048710834199 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- Insiders Buying GNC – Michael Wiggins De Oliveira’s Idea Of The Month – Seeking Alpha (seekingalpha.com)
- Investor’s Alert (Technicals Data Analysis): GNC Holdings Inc (NYSE: GNC) – Alpha Beta Stock (alphabetastock.com)
- Stock’s Technical Analysis – GNC Holdings Inc (NYSE: GNC) – Alpha Beta Stock (alphabetastock.com)
- A Look at Price Fluctuation of GNC Holdings Inc (GNC) – ExpertGazette (expertgazette.com)
- GNC: Super Undervalued And Here Is Why – Seeking Alpha (seekingalpha.com)
Shares of GNC (NYSE GNC) traded down $0.01 on Wednesday, reaching $4.20. The company had a trading volume of 1,743,117 shares, compared to its average volume of 6,241,406. The stock has a market cap of $364.35, a PE ratio of -2.00 and a beta of 0.89. GNC has a 1 year low of $3.13 and a 1 year high of $10.95. The company has a debt-to-equity ratio of -55.95, a current ratio of 2.44 and a quick ratio of 0.70.
Several equities research analysts have commented on GNC shares. ValuEngine cut shares of GNC from a “strong-buy” rating to a “buy” rating in a research report on Thursday, December 21st. Zacks Investment Research upgraded shares of GNC from a “sell” rating to a “hold” rating in a research report on Tuesday, January 23rd. JPMorgan Chase & Co. dropped their price target on shares of GNC from $7.00 to $6.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 14th. Finally, Barclays dropped their price target on shares of GNC from $9.00 to $6.00 and set an “underweight” rating on the stock in a research report on Friday, October 27th. Five investment analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $7.77.
COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3212512/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-gnc-gnc-share-price.html.
GNC Company Profile
GNC Holdings, Inc is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company’s operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products.
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.